Status:
RECRUITING
Role of the Environment and Endocrine Disruptors in Child Cryptorchidism
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
University Hospital, Bordeaux
Conditions:
Cryptorchidism
Eligibility:
MALE
1-18 years
Brief Summary
Cryptorchidism is the most frequent congenital defect of the male newborn. It requires surgery in childhood, increases the risk of fertility disorders and cancer. As a major public health objective, i...
Detailed Description
Cryptorchidism is the most frequent congenital defect of the male newborn. It requires surgery in childhood, increases the risk of fertility disorders and cancer. As a major public health objective, i...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Parents of male children from the neonatal period to 18 years of age (during surgery) with cryptorchidism
- Exclusion criteria:
- Parents of children without endocrine disease. (adrenal, hypothalamic-pituitary, phosphocalcic, thyroid, diabetes, etc.)
- Parents of children without an associated genital or urinary defect (hypospadias, micropenis, renal and bladder abnormalities)
- Testicular Ectopia (testis outside of normal migration path)
- Anorchidism and evanescent testicles, united or bilateral
- Abnormalities of the abdominal wall (laparoschisis, omphalocele, Prune Belly)
- Cryptorchidism integrating in the context of a polymalformative syndrome, including neurological.
Exclusion
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2028
Estimated Enrollment :
1452 Patients enrolled
Trial Details
Trial ID
NCT04342026
Start Date
April 16 2020
End Date
April 15 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Montpellier
Montpellier, France, 34295